Principal Healthcare Innovators ETF Rating → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free BTEC Stock Alerts $34.30 +0.70 (+2.08%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial MediaStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestSocial Media Principal Healthcare Innovators ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BTEC Aggregate RatingModerate Buy2.73Holdings in BTEC have an aggregate rating of Moderate Buy based on 492 analyst ratings issued in the past year covering 50 companies (60.4% of the portfolio).BTEC Aggregate Price Target$47.0237.10% UpsideHigh Prediction$64.58Average Prediction$47.02Low Prediction$32.13Holdings in BTEC have an aggregate price target of $47.02 and a range of $32.13 to $64.58 covering 50 companies (60.4% of the portfolio).BTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Principal Healthcare Innovators ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BTEC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.23%ALNYAlnylam Pharmaceuticals$143.31-0.3%5 of 5 stars2.59$215.88 50.6%17Upcoming EarningsShort Interest ↓News Coverage3.23%MRNAModerna$107.97+1.7%4 of 5 stars2.25$126.49 17.1%16Upcoming EarningsInsider Selling2.87%ILMNIllumina$122.28+1.0%5 of 5 stars2.32$167.70 37.1%19Upcoming Earnings2.56%EXASExact Sciences$58.85+0.1%4 of 5 stars2.86$97.44 65.6%14Short Interest ↑2.47%SRPTSarepta Therapeutics$128.77+1.1%4 of 5 stars2.79$156.60 21.6%14Analyst RevisionNews Coverage2.43%NTRANatera$91.66+0.4%2 of 5 stars3.00$86.40 -5.7%14Analyst DowngradeInsider Selling2.26%CTLTCatalent$55.92+0.2%3 of 5 stars2.15$52.46 -6.2%13Analyst ReportNews CoveragePositive News1.88%ROIVRoivant Sciences$11.03+1.4%4 of 5 stars2.90$16.90 53.2%10Short Interest ↑1.69%CERECerevel Therapeutics$42.47+1.0%0 of 5 stars2.20$41.40 -2.5%10Upcoming EarningsShort Interest ↓1.67%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst ReportAnalyst Revision1.63%VKTXViking Therapeutics$74.31+7.9%5 of 5 stars3.00$112.25 51.1%10Earnings ReportAnalyst ReportAnalyst Revision1.62%INSPInspire Medical Systems$237.45+2.8%4 of 5 stars2.71$272.20 14.6%14Positive News1.57%CYTKCytokinetics$65.34+0.8%4 of 5 stars2.87$79.33 21.4%15Insider SellingShort Interest ↑News Coverage1.52%PCVXVaxcyte$60.72+1.1%2 of 5 stars3.00$78.50 29.3%4Insider SellingNews Coverage1.48%ELANElanco Animal Health$13.26+1.7%4 of 5 stars2.57$16.71 26.1%7Short Interest ↑1.37%RVMDRevolution Medicines$35.96+1.8%4 of 5 stars3.10$41.20 14.6%10Positive News1.34%IONSIonis Pharmaceuticals$41.59-0.6%4 of 5 stars2.69$56.08 34.8%13Upcoming Earnings1.30%APLSApellis Pharmaceuticals$49.86+4.0%4 of 5 stars2.87$77.93 56.3%15Analyst ReportAnalyst RevisionNews CoverageGap Up1.22%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up1.09%GKOSGlaukos$99.48-0.6%4 of 5 stars2.78$99.80 0.3%9Upcoming EarningsShort Interest ↓1.04%BBIOBridgeBio Pharma$24.88+2.3%4 of 5 stars2.80$47.82 92.2%10Upcoming EarningsShort Interest ↑Positive News1.03%MDGLMadrigal Pharmaceuticals$193.33-0.5%5 of 5 stars2.73$356.73 84.5%110.98%ALPNAlpine Immune Sciences$64.56-0.1%2 of 5 stars2.27$50.33 -22.0%11Short Interest ↓0.94%IMVTImmunovant$27.17-2.1%3 of 5 stars3.00$48.00 76.7%17Insider SellingShort Interest ↓Analyst Revision0.89%INSMInsmed$24.80-0.5%4 of 5 stars3.00$44.92 81.1%12Analyst ReportNews Coverage0.86%NUVLNuvalent$66.86+1.2%3 of 5 stars2.90$90.78 35.8%10Insider Selling0.83%RAREUltragenyx Pharmaceutical$44.24+0.9%4 of 5 stars2.92$88.08 99.1%12Upcoming EarningsAnalyst Report0.82%BHVNBiohaven$38.97+1.1%4 of 5 stars3.00$52.13 33.8%8Analyst ReportInsider BuyingAnalyst RevisionNews Coverage0.81%IBRXImmunityBio$7.35+43.8%0 of 5 stars2.00$5.00 -32.0%1Options VolumeNews CoverageHigh Trading Volume0.79%IRTCiRhythm Technologies$111.91+0.6%0 of 5 stars3.00$135.11 20.7%7Upcoming EarningsShort Interest ↑0.78%CRNXCrinetics Pharmaceuticals$42.12-0.4%4 of 5 stars2.91$54.00 28.2%11Upcoming EarningsShort Interest ↑0.75%IOVAIovance Biotherapeutics$11.64+0.9%5 of 5 stars3.00$24.64 111.7%10Short Interest ↑0.75%AXSMAxsome Therapeutics$71.71+0.3%4 of 5 stars2.92$119.67 66.9%120.74%SWTXSpringWorks Therapeutics$45.53+3.0%3 of 5 stars3.00$68.00 49.4%6Upcoming EarningsNews Coverage0.71%FOLDAmicus Therapeutics$10.28+1.1%4 of 5 stars3.00$20.00 94.6%3Positive News0.70%TXG10x Genomics$27.59+2.6%4 of 5 stars2.89$60.22 118.3%9Upcoming EarningsNews Coverage0.70%ENOVEnovis$55.26+0.3%3 of 5 stars3.00$75.43 36.5%8Upcoming Earnings0.69%IDYAIDEAYA Biosciences$39.94+3.4%3 of 5 stars3.00$46.60 16.7%120.67%TMDXTransMedics Group$92.08+3.2%1 of 5 stars2.86$102.00 10.8%7Upcoming Earnings0.65%AZTAAzenta$52.18+1.3%3 of 5 stars2.33$69.60 33.4%6Short Interest ↑0.65%ACLXArcellx$51.92+1.1%3 of 5 stars3.00$75.64 45.7%12Short Interest ↑0.64%ARWRArrowhead Pharmaceuticals$22.12+1.1%4 of 5 stars2.64$50.80 129.7%11News Coverage0.61%PRCTPROCEPT BioRobotics$51.83-0.9%0 of 5 stars3.00$45.60 -12.0%6Upcoming EarningsNews Coverage0.59%CLDXCelldex Therapeutics$36.30+0.1%1 of 5 stars2.80$66.00 81.8%5Upcoming Earnings0.58%JANXJanux Therapeutics$47.39+0.6%4 of 5 stars3.00$61.33 29.4%7Positive News0.58%SMMTSummit Therapeutics$3.86+8.7%1 of 5 stars3.00$8.00 107.3%1Upcoming EarningsGap Up0.56%CGONCG Oncology$41.00+13.3%1 of 5 stars2.75$61.75 50.6%4Analyst RevisionNews CoverageHigh Trading Volume0.54%DNLIDenali Therapeutics$15.43+3.1%3 of 5 stars3.00$41.22 167.2%8News Coverage0.54%ICUIICU Medical$94.84+0.3%4 of 5 stars3.00$123.00 29.7%2Short Interest ↑0.54%RYTMRhythm Pharmaceuticals$38.28+0.3%2 of 5 stars3.00$47.20 23.3%5Analyst Report This page (NASDAQ:BTEC) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Principal Healthcare Innovators ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
